| Issue |
Med Sci (Paris)
Volume 34, Number 5, Mai 2018
|
|
|---|---|---|
| Page(s) | 391 - 394 | |
| Section | Le Magazine | |
| DOI | https://doi.org/10.1051/medsci/20183405007 | |
| Published online | 13 June 2018 | |
Carcinome hépatocellulaire après éradication du virus de l’hépatite C par les antiviraux à action directe
Prochains défis
Risk of hepatocellular carcinoma after hepatitis C virus cure with direct-acting antivirals: the next challenges
1
Inserm U1110, institut de recherche sur les maladies virales et hépatiques, 3, rue Koeberlé, 67000 Strasbourg, France
2
Université de Strasbourg, 67000 Strasbourg, France
3
Institut hospitalo-universitaire, pôle hépato-digestif, nouvel hôpital civil, 67000 Strasbourg, France
4
Inserm U1052, CNRS UMR 5286, centre de recherche sur le cancer de Lyon (CRCL), université de Lyon (UCBL), 151, cours Albert Thomas, 69424 Lyon, France
Cet article ne possède pas de résumé.
© 2018 médecine/sciences – Inserm
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.
